DGX vs DOCS Stock Comparison
Compare DGX and DOCS across AIQ Score, fundamentals, valuation, momentum, risk, analyst expectations and current market evidence.
What is the main difference between DGX and DOCS?
DOCS leads the current stock comparison as Doximity, Inc., with the clearest separation coming from quality and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
Quest Diagnostics Incorporated vs Doximity, Inc.
DOCS leads
DOCS leads by 8 AIQ points, primarily on Quality and Momentum, and the lead has widened from 5 points over 30 sessions.
Fragile: 3 of 6 evidence groups support DOCS, and its lead is widening.
Quest Diagnostics Incorporated
Doximity, Inc.
The Algovestiq AIQ Score currently favors DOCS over DGX, 57 versus 49 as of Sep 11, 2026. DOCS's advantage is driven primarily by stronger quality and momentum, while DGX holds the stronger value profile. DOCS also shows the stronger technical structure relative to its 50-day moving average. 3 of 6 covered evidence groups favor DOCS today, and the comparison is rated Fragile on stability: only 3 of 6 covered evidence groups agree. DOCS lead: Strengthening — the AIQ differential moved from 5 to 8 points over 30 sessions.
Compare Quest Diagnostics Incorporated and Doximity, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Price-return comparison using available daily close history.
Total return comparison
Growth of $10,000
Based on available close-price history. Distribution reinvestment is not added unless already reflected in the source series.
Compare DGX and DOCS against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Quality47 vs 77DOCS +30
- Value53 vs 46DGX +7
- Momentum40 vs 47DOCS +7
- Risk Resilience60 vs 56DGX +4
3 of 6 evidence groups favor DOCS. DOCS’s edge is concentrated in quality and momentum; DGX keeps a meaningful value edge.
What changed since the last close
Latest scored session 2026-09-10, compared against the prior scored session 2026-09-09.
Largest factor move: Momentum -5
No new signals fired.
Largest factor move: Momentum +2
No new signals fired.
DOCS's lead widened by 1 AIQ points in the latest snapshot.
Deeper signal detail for each name lives on its own signals page — DGX and DOCS both carry a full feed there.
The central trade-off
DOCS (Doximity, Inc.): the stronger current systematic profile, led by quality and momentum.
DGX (Quest Diagnostics Incorporated): the counter-case, on value, risk resilience, valuation.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
DOCSDOCS on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
DOCSDOCS on combined revenue and EPS growth.
Value
DGXDGX on the peer-relative Value factor, by 7 points.
Momentum
DOCSDOCS on the Momentum factor, by 7 points.
Lower downside
DGXDGX on Risk Resilience, by 4 points.
Analyst upside
DOCSDOCS on implied upside to the consensus price target.
AIQ vs Wall Street
Where the systematic read and the analyst consensus line up — and where they do not.
| Measure | DGX | DOCS | Note |
|---|---|---|---|
| Implied upside to target | +1.1% | +6.3% | DOCS has more room |
| Target dispersion | +21% | +84.6% | Lower is tighter analyst agreement |
| Consensus | Buy | Buy | Context, not a primary driver |
| Analysts covering | 6 | 14 | Higher coverage generally improves confidence |
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
3 of 6 covered evidence groups favor DOCS. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | DOCS | 49 vs 57 |
| Fundamentals | DOCS | revenue growth 5.1% vs 7.7%; EPS growth 26.9% vs 30%; TTM ROE 14.5% vs 17%; gross margin 33.1% vs 88.1%; operating margin 14.1% vs 29.6% |
| Valuation | DGX | Value 53 vs 46 |
| Technicals | DGX | Price vs 50-day 2.7% vs 8.7%; vs 200-day 14.5% vs -13.4% |
| Risk Resilience | DGX | Risk Resilience 60 vs 56 |
| Analyst expectations | DOCS | Target upside 1.1% vs 6.3% |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of DGX and DOCS and are excluded from the count.
AIQ Decision Stability
The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.
- The AIQ gap is moderate at 8 points.
- Only 3 of 6 covered evidence groups agree. (argues the conclusion is provisional)
- The leader's advantage has been widening. (supports the conclusion holding)
- Signal direction runs against the verdict: the leader is net-bearish while the laggard is net-bullish. (argues the conclusion is provisional)
- Analyst targets on the leader are widely dispersed. (argues the conclusion is provisional)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on DOCS.
How the comparison changed
119 daily snapshots · May 4 – Sep 10DOCS lead: Strengthening — the AIQ differential moved from 5 to 8 points over 30 sessions.
- Today
- DOCS +8
- 49 vs 57
- 7 sessions ago
- DOCS +8
- 54 vs 62
- 30 sessions ago
- DOCS +5
- 56 vs 61
- 90 sessions ago
- DOCS +5
- 58 vs 63
The lead changed hands 9 times in this window, most recently on Aug 28 when DOCS moved ahead of DGX.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
3 bullish / 1 bearish, conflicted
- Golden Cross Active — bullish, trend, long horizon (13.42%)
- EMA Ribbon Expansion Bullish — bullish, trend, medium horizon
- Uptrend Structure Active — bullish, trend, long horizon
0 bullish / 2 bearish / 2 neutral
- Death Cross Active — bearish, trend, long horizon (21.25%)
- Bollinger Band Squeeze — neutral, volatility, short horizon
- ATR Expansion - Breakout Mode — neutral, volatility, short horizon (5.35%)
DGX is conflicted, so the timing case there is weaker than the score alone suggests.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Price is up while the AIQ Score moved down 1 points over the same session — price and model disagree (price +1.68%, AIQ -1 points).
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +3.52%, AIQ 0 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1DGX closes the Quality gap — currently 30 points behind, the largest single contributor to DOCS's edge.
- 2DGX generates a confirmed bullish trend signal it does not currently carry, such as MACD Bullish Crossover.
- 3DOCS starts generating bearish momentum or trend signals.
- 4A regime shift changes factor weighting — Quality and Value carry the heaviest weights in the composite, so a rotation toward either would move the result most.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
DOCS leads on balance| Metric | DGX | DOCS |
|---|---|---|
| Revenue growth (YoY) | 5.1% | 7.7% |
| EPS growth (YoY) | 26.9% | 30% |
| Gross margin | 33.1% | 88.1% |
| Operating margin | 14.1% | 29.6% |
| Return on equity (TTM) | 14.5% | 17% |
| Debt to equity | 0.85 | 0.01 |
Performance
DGX leads 4 of 6 windows| Metric | DGX | DOCS |
|---|---|---|
| 1 week (5 sessions) | -4% | -6.1% |
| 1 month (20 sessions) | -2.8% | -1.1% |
| 3 months (63 sessions) | 13.4% | 22.1% |
| 6 months (126 sessions) | 15.2% | 0.3% |
| Year to date | 33.2% | -44.2% |
| 1 year (252 sessions) | 26.6% | -64.5% |
Technicals
DGX has the stronger structure| Metric | DGX | DOCS |
|---|---|---|
| RSI (14) | 31.7 | 42.1 |
| ADX (14) | 28 | 35.7 |
| Price vs 50-day | 2.7% | 8.7% |
| Price vs 200-day | 14.5% | -13.4% |
| Volatility (1M, annualized) | 16.9% | 54.2% |
Risk
DGX is the more resilient| Metric | DGX | DOCS |
|---|---|---|
| Beta | -0.13 | 0.63 |
| Sharpe ratio | 0.94 | -1.38 |
| Sortino ratio | 1.81 | -1.76 |
| Max drawdown | -11.9% | -76% |
| Current drawdown | -5.7% | -67.1% |
| Annualized volatility | 23.8% | 63.6% |
| Value at risk (95%) | -2% | -5.6% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, DGX or DOCS?
On the Algovestiq AIQ Score, DOCS is the stronger of the two as of Sep 11, 2026, scoring 57 against DGX's 49. The edge comes from quality and momentum. DGX is not without a case — it holds the better value profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is DGX or DOCS the better buy right now?
DOCS carries the stronger systematic profile as of Sep 11, 2026, and the comparison is rated Fragile — 3 of 6 covered evidence groups agree. A Fragile rating means the conclusion is sensitive: only 3 of 6 covered evidence groups agree. Treat the lead as provisional.
Why does the AIQ Score favor DOCS over DGX?
The composite weights Quality, Value, Momentum and Risk Resilience. DOCS leads Quality by 30 points; DGX leads Value by 7 points; DOCS leads Momentum by 7 points. Where the two split, the factor with the larger weight carries the result.
Which has more analyst upside, DGX or DOCS?
Analyst price targets imply +1.1% upside for DGX and +6.3% for DOCS, so the Street currently favors DOCS. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, DGX or DOCS?
DGX is the better-valued of the two on the peer-relative Value factor. DGX on the peer-relative Value factor, by 7 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, DGX or DOCS?
DOCS on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, DGX or DOCS?
DOCS on the Momentum factor, by 7 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, DGX or DOCS?
DGX is the more resilient of the two, so the other name carries the higher downside risk. DGX on Risk Resilience, by 4 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is DGX more profitable than DOCS?
DOCS leads on the comparable margin measures — gross margin 33.1% vs 88.1%; operating margin 14.1% vs 29.6%; ttm roe 14.5% vs 17%.
Is DOCS's lead over DGX getting stronger or weaker?
DOCS lead: Strengthening — the AIQ differential moved from 5 to 8 points over 30 sessions. This is measured from 119 daily comparison snapshots between 2026-05-04 and 2026-09-10. The lead has changed hands 9 times in that window, most recently on 2026-08-28, when DOCS moved ahead of DGX.
What would change the DGX vs DOCS verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: DGX closes the Quality gap — currently 30 points behind, the largest single contributor to DOCS's edge; DGX generates a confirmed bullish trend signal it does not currently carry, such as MACD Bullish Crossover; DOCS starts generating bearish momentum or trend signals; a regime shift changes factor weighting — Quality and Value carry the heaviest weights in the composite, so a rotation toward either would move the result most.
What do the current signals say about DGX and DOCS?
DGX: 3 bullish / 1 bearish, conflicted. DOCS: 0 bullish / 2 bearish / 2 neutral. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on DGX is Golden Cross Active (bullish, long horizon). On DOCS it is Death Cross Active (bearish, long horizon).
Compare DGX and DOCS with others
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.